HIV Prophylaxis: Preventing HIV Before and After Exposure

Human Immunodeficiency Virus (HIV) remains a major global health concern, but modern medicine has developed powerful tools to prevent infection. One of the most effective strategies is HIV prophylaxis, which refers to medications taken to prevent HIV infection either before or after potential exposure to the virus. Understanding how prophylaxis works can help individuals at risk protect their health and reduce the spread of HIV.

What is HIV Prophylaxis?

HIV prophylaxis involves the use of antiretroviral medications to prevent HIV infection. These medicines stop the virus from multiplying in the body if exposure occurs. HIV prophylaxis is mainly divided into two types:

1. Pre-Exposure Prophylaxis (PrEP)
2. Post-Exposure Prophylaxis (PEP)

Both strategies are highly effective when used correctly and under medical supervision.

Pre-Exposure Prophylaxis (PrEP)

PrEP is a preventive medication taken by people who do not have HIV but are at high risk of getting it. It is typically taken daily and can reduce the risk of HIV transmission through sexual contact by over 90%, and through injection drug use by around 70% or more when used consistently.

Who Should Consider PrEP?

PrEP may be recommended for individuals who:

• Have a sexual partner living with HIV
• Have multiple sexual partners without consistent condom use
• Have been diagnosed with sexually transmitted infections (STIs)
• Inject drugs and share needles or equipment
• Are part of populations with higher HIV prevalence

How PrEP Works

PrEP medications contain antiretroviral drugs that build protective levels in the bloodstream. If HIV enters the body, these drugs prevent the virus from establishing a permanent infection.

Monitoring While on PrEP

Individuals taking PrEP require regular medical follow-ups, typically every three months, which may include:

• HIV testing
• Kidney function tests
• Screening for other STIs
• Adherence counseling

Post-Exposure Prophylaxis (PEP)

PEP is an emergency intervention used after a potential exposure to HIV. It must be started within 72 hours of exposure and taken daily for 28 days.

Situations Where PEP May Be Used

PEP may be recommended after:

• Unprotected sexual contact with someone whose HIV status is unknown or positive
• Needle-stick injuries in healthcare settings
• Sharing injection drug equipment
• Sexual assault

Effectiveness of PEP

PEP can significantly reduce the risk of HIV infection when started quickly and taken as prescribed. The earlier treatment begins, the more effective it is.

Importance of Early Testing and Medical Care

Before starting prophylaxis, individuals are usually tested for HIV to ensure they are not already infected. If HIV infection is detected, full antiretroviral therapy (ART) is required instead of prophylaxis.

Regular testing also ensures that prophylaxis remains safe and effective.

Safety and Side Effects

Most HIV prophylaxis medications are well tolerated. Some people may experience mild side effects such as:

• Nausea
• Headache
• Fatigue
• Mild gastrointestinal discomfort

These symptoms usually improve after the first few weeks of treatment.

HIV Prophylaxis in Public Health

HIV prophylaxis has become an essential part of global HIV prevention strategies. When combined with other preventive measures—such as condom use, regular testing, and harm-reduction programs—PrEP and PEP can dramatically reduce new HIV infections.

Conclusion

HIV prophylaxis offers a powerful way to prevent HIV infection for people at risk. Whether used as PrEP before exposure or PEP after potential exposure, these medications provide an important layer of protection. Increased awareness, access to healthcare, and routine testing are key to maximizing the benefits of HIV prophylaxis and moving closer to ending the HIV epidemic.

If you believe you may benefit from HIV prophylaxis, consult a qualified healthcare professional to discuss the most appropriate preventive strategy for your situation.